Annovis BioAdvance News Portfolio News

QR Pharma Adopts new Corporate Name: Annovis Bio

By WebmasterJune 24, 2019November 1st, 2024No Comments

QR Pharma Adopts new Corporate Name: Annovis Bio
Change reflects enhanced focus on neurodegenerative diseases

Previous PostImmunome Appoints Purnanand Sarma, PhD, as President and Chief Executive Officer
Next PostNemours Children's Health System Expands Partnership with Bainbridge Health to Support Its Continued Commitment to Medication Safety